Location: Home > Pharma China Web Edition
  • search
  • go
  • Editor's Picks
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/5/2024Big Pharma Doubles Down on China (The Wire China)
  • 12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)
  • 12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
  • 11/27/2024Asian Market Rattled by Trump Tariffs: Yang Report (LinkedIn)
  • 11/26/2024Rise In Clinical Trial Activity Will Support Hong Kong, China’s Pharm...
  • 11/22/2024Cancer Incidence and Mortality in China, 2022 (JNCC)
  • 11/20/2024 Promoting Collaboration in Regional Healthcare Systems in Hong Kong, ...
  • 11/20/2024Probe of AstraZeneca Executive in China Raises Questions About Company...
  • 11/19/2024Pharma BoardRoom Interview of Renaud Gabay – Managing Director, RDPAC...
  • 11/19/2024When BeiGene Takes Off 'Bei' and Why NewCo Now: Three Biotech Go Globa...
  • 11/14/2024China on the Move: New Level of Opening up in Health Care Sector (NLR)
  • 11/14/2024Passage to Asia: Early Access for Innovative Therapies (PharmExec)
  • 11/13/2024How China's Anti-Espionage Law Could Impact Pharmaceutical Supply Chai...
  • 11/12/2024Life Sciences M&A Trends for 2023 And 2024 (Thru Q3) in Greater China ...
  • 11/12/2024Precision Oncology Drug Development in China: Opportunities, Challenge...
  • 11/12/2024Trump Presidency to Test Public Trust in Big Pharma (SWI)
  • 11/11/2024China Biotech and the Bear: A Perspective (BioCentury)
  • 11/11/2024Trump's Trade Tango Returns: Will China's Biotech Dance Through Anothe...
  • 11/11/2024China Biopharma Tracker – October 2024 (PharmaDJ)
  • 11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...
  • 11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...
  • 11/4/2024Big Pharma Doubles Down on China (The Wire China)
  • 11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...
  • 11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...
  • 10/31/2024China Investigation of Drug Firm Exec Deals Latest Blow to Foreign Bus...
  • 10/31/2024AstraZeneca's China Legal Woes Follow Push For Market Share (Bloomberg...
  • 10/30/2024China's Compliance Guidelines for Healthcare Companies Signal Areas of...
  • Page:3/7 Total number of articles:182: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group